The effect of aminomethylpteroylglutamic acid on the development of skin hypersensitivity and on antibody formation in guinea pigs.
1. In guinea pigs, aminomethylpteroylglutamic acid (methotrexate) is capable of blocking the development of delayed skin hypersensitivity, the primary antibody response, and the specific febrile response to ovalbumin and diphtheria toxoid. The primary antibody response is more easily inhibited than is the development of delayed skin hypersensitivity. 2. The effect of methotrexate on immunologic responses depended upon the dose of methotrexate employed and the strength of the antigenic stimulus.
D000818:Animals; D000906:Antibodies; D000917:Antibody Formation; D000941:Antigens; D003876:Dermatitis, Atopic; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D006168:Guinea Pigs; D006801:Humans; D006968:Hypersensitivity, Delayed; D010047:Ovalbumin; D012867:Skin / Q000494:pharmacology*
D000906:Antibodies; D000941:Antigens; D005493:Folic Acid Antagonists; D010047:Ovalbumin
ANTIBODIES; FOLIC ACID ANTAGONISTS/pharmacology; SKIN/pharmacology